Global In Situ Hybridization Industry to 2025 - Untapped Markets in Developing Countries Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "In Situ Hybridization (ISH) Market by Product (Consumables (Kits, Probes) Software), Technology (FISH (DNA, RNA), CISH), Application (Cancer, Infectious Disease), and End User (Diagnostic Labs, Research Institutes, CROs), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.

The increasing incidence of cancer and awareness of companion diagnostics test are the major factors driving the growth of this market. However, the lack of skilled professionals poses a challenge to the ISH market.

By consumables type, the kits & reagents accounted for the fastest-growing segment of the ISH market.

The kits & reagents segment accounted for the largest share of this market in 2019. The rise in government and private funding in life sciences and cancer research, the increasing number of reagent rental agreements, and the application of innovative technologies and methodologies in the fields of tissue and in vitro diagnostics are expected to drive the growth of the ISH consumables market during the forecast period.

By technology type, the FISH segment accounted for the largest share of the ISH market.

Based on technology, the ISH market is segmented broadly into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). This segment accounted for the largest share of the global ISH market in 2019. The large share of this segment is attributed to the increasing demand for FISH kits and assays in CDx for cancer diagnostics, chromosomal abnormalities, and infectious diseases.

Asia Pacific: The fastest-growing region in the ISH market.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, The economic growth in the countries of this region, its large population base, the rising prevalence of chronic diseases, improvements in the standard of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and awareness regarding the use of tissue diagnostic tests (including ISH) are the major factors driving market growth in the APAC

North America: the largest share of the ISH market.

North America accounted for the largest share of the ISH market. The large share of this segment can primarily be attributed to the presence of major players operating in the ISH market in the US, rising incidence of cancer and infectious diseases, and the increasing adoption of companion diagnostic assay kits.

Market Dynamics

Market Drivers

• Increasing Incidence of Genetic Disorders and Cancer
• Awareness About Companion Diagnostics

Opportunities

• Untapped Markets in Developing Countries

Challenges

• Lack of Skilled Professionals

Companies Profiled

• Abbott Laboratories
• F. Hoffmann-La Roche
• Agilent Technologies
• Thermo Fisher Scientific
• Bio-Techne Corporation
• Qiagen N.V.
• Danaher Corporation
• Perkinelmer
• Enzo Biochem
• Bio-Rad Laboratories
• Merck Kgaa
• Abnova Corporation
• Biogenex Laboratories
• Biocare Medical
• Opgen
• Bio Sb
• Genemed Biotechnologies
• Abcam
• Creative Bioarray
• Biocat GmbH
• Zytovision

For more information about this report visit https://www.researchandmarkets.com/r/4lx14s